UMC Utrecht: clinical-trial pipeline
UMC Utrecht is the sponsor of 363 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 74 are not yet finished and 1 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 251 |
| Phase 4 | 35 |
| Phase 3 | 32 |
| Phase 2 | 23 |
| Phase 1/2 | 9 |
| Phase 1 | 8 |
| Phase 2/3 | 5 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 160 |
| Unknown | 83 |
| Recruiting | 54 |
| Terminated | 36 |
| Active, not recruiting | 10 |
| Not yet recruiting | 10 |
| Withdrawn or not authorised | 9 |
| Suspended or halted | 1 |
Condition areas
| Area | Trials |
|---|---|
| Cardiovascular | 93 |
| Oncology | 88 |
| Infectious disease and vaccines | 40 |
| Gastroenterology and liver | 28 |
| Neurology | 25 |
| Rare and genetic diseases | 25 |
| Respiratory | 21 |
| Immunology and rheumatology | 20 |
| Women's health and obstetrics | 20 |
| Nephrology and urology | 18 |
| Psychiatry and mental health | 17 |
| Metabolic and endocrine (diabetes, obesity) | 15 |
Countries
| Country | Trials |
|---|---|
| Netherlands | 338 |
| Belgium | 14 |
| Italy | 13 |
| United Kingdom | 12 |
| Spain | 11 |
| Germany | 9 |
| Canada | 6 |
| Denmark | 5 |
| France | 5 |
| Romania | 5 |
| Serbia | 5 |
| United States | 5 |
| Czechia | 4 |
| Finland | 4 |
| Hungary | 4 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-21 | New trial posted | Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | Phase 3 | Active, not recruiting | Australia, Belgium, Canada, Switzerland +25 |
| NCT06191120 | FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype | Not applicable | Recruiting | Netherlands |
| NCT03171818 | Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration | Phase 2 | Recruiting | Netherlands |
| NCT05662111 | Treatment of Ectopic Calcification in Fahr's Disease or Syndrome | Phase 2 | Recruiting | United Kingdom, Netherlands |
| NCT05832580 | The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum | Phase 3 | Active, not recruiting | Netherlands |
| NCT07562971 | Focused Ultrasound Blood-Brain Barrier Opening in Pontine Diffuse Midline Glioma to Enhance Temozolomide Ther… | Phase 1/2 | Not yet recruiting | Netherlands |
| NCT07831746 | Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy | Phase 2/3 | Not yet recruiting | Netherlands |
| NCT07668856 | Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualiz… | Phase 3 | Recruiting | Netherlands |
| NCT04364334 | Knee Registry (Knieregister) | Not applicable | Recruiting | Netherlands |
| NCT02356497 | Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort | Not applicable | Recruiting | Netherlands |
| NCT05809310 | Effects Branch PA Stenting d-TGA, ToF and TA | Not applicable | Recruiting | Netherlands |
| NCT05216900 | Breast Reconstruction and Neoadjuvant Radiotherapy | Not applicable | Recruiting | Netherlands |
| NCT02839863 | Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA Cohort | Not applicable | Recruiting | Netherlands |
| NCT06563986 | FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer | Phase 2 | Recruiting | Netherlands |
| NCT06898541 | Coronary Sinus Reducer in Coronary Microvascular Disease | Not applicable | Recruiting | Netherlands |
| NCT06124248 | Effectiveness of the RISE Intervention | Not applicable | Recruiting | Netherlands |
| NCT05992038 | Use of a Putty as Gap Filler in Open-wedge Osteotomy | Not applicable | Recruiting | Netherlands |
| NCT07640711 | Innovative Brain-Computer Interface for People With Spinal Cord Injury | Not applicable | Recruiting | Netherlands |
| NCT05069792 | Utrecht COhort for Lung Cancer Outcome Reporting and Trial Inclusion (U-COLOR) | Not applicable | Active, not recruiting | Netherlands |
| NCT04120298 | Effects of Exercise in Patients With Metastatic Breast Cancer | Not applicable | Active, not recruiting | Netherlands |
| NCT04881487 | Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy | Not applicable | Recruiting | Netherlands |
| NCT04228211 | Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation | Not applicable | Recruiting | Netherlands |
| NCT06272162 | Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy | Not applicable | Not yet recruiting | Netherlands |
| NCT05078619 | Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation | Not applicable | Active, not recruiting | Netherlands |
| NCT07051356 | Wearables and Artificial Intelligence in Advanced Heart Failure Care | Not applicable | Not yet recruiting | Netherlands |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "UMC Utrecht clinical trials: 74 open, 37 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/umc-utrecht/, data as of 2026-10-25.